PMS11 INFLIXIMAB COSTS AND REASONS FOR TREATMENT...

Value in Health 2019 / 05 Vol. 22

PMS11 INFLIXIMAB COSTS AND REASONS FOR TREATMENT DISCONTINUATION AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TREATMENT IN U.S. HOSPITALS: 2012-2015

Rosenthal, N., Wu, D., Arsever, C., Kartashov, A., Baumer, D.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.1122
Date:
May, 2019
File:
PDF, 383 KB
2019
Conversion to is in progress
Conversion to is failed